Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Phase
3Span
204 weeksSponsor
Alumis IncPonce
Recruiting
A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)
Phase
2Span
128 weeksSponsor
Merck Sharp & Dohme LLCPonce
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Phase
2Span
136 weeksSponsor
Vaxcyte, Inc.Ponce
Recruiting
Healthy Volunteers
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
Phase
3Span
140 weeksSponsor
ModernaTX, Inc.Ponce
Recruiting
Healthy Volunteers
A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001
Phase
3Span
97 weeksSponsor
Alumis IncPonce
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
Phase
2Span
60 weeksSponsor
PfizerPonce
Recruiting
Healthy Volunteers
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
Phase
2Span
148 weeksSponsor
PfizerPonce
Recruiting
Healthy Volunteers
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Phase
3Span
265 weeksSponsor
Eli Lilly and CompanyPonce
Recruiting
Study of JK07 in Patients With Chronic Heart Failure
Phase
2Span
118 weeksSponsor
Salubris Biotherapeutics IncPonce
Recruiting
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
Phase
3Span
105 weeksSponsor
Endo PharmaceuticalsPonce
Recruiting
1-10 of 47